Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: SPN-817
Total 0 results
Nothing found
Sponsors and Collaborators
Nutrabolt
Vivid Pharma Inc.
HBSA
Huisartspraktijk Handellaan
Shanghai GeneChem Co., Ltd.
Université de Genève (UNIGE)
Salena Killion
The Affiliated Hospital of Xuzhou Medical University
Zhongda Hospital, Medical School, Southeast University
Cogniciti
Defence Services Medical Academy (DSMA), Myanmar
Impulse Dynamics, Inc.
BioNova Pharmaceuticals (Shanghai) LTD.
Pia Jaeger, MD, PhD
Hungarian Dental Association
Smart Meter Corporation
Health Information Technology Solutions (HITS) LLC
NERv Technology Inc
UNITI Consortium
Ministry of Public Health, Cameroon
View Full List
Medical Conditions
Old Age (Focus; Not a Recognized Condition)
Vertebral Compression Fractures in Osteoporotic Patients
Advanced Bladder Carcinoma
Biomarkers, Pharmacological
Cardiovascular Primary Prevention
Alzheimer Disease Focal
VEXAS Syndrome
Failed Induction
Eye Disease, Hereditary
Radiofrequency Ablation Treatment
SMA - Spinal Muscular Atrophy
PPA Syndrome
Premature Rupture of Membranes Prolonged
Research Mentoring Skills
Cerebral Arterial Disease
Infection, Bacterial
PET-CT Specimen Imager
Immediate Implant Placement
Endoleaks
Pain, Breakthrough
View Full List
Drug Interventions
Lacosamide
5 FU continuous
Acetylsalicylic acid
80% oxygen
HPN328
Oxymorphone hydrochloride (HCl)
TQB2450
Cefadroxil until drain removal
0.75% Ropivacaine
CNTO 6785 50 mg
Phase B: Triplixam / Elestar HCT
20 mg/kg IV FL-301
Rosuvastatin
18F-FDG
Durvalumab + chemotherapy treatment
Olopatadine hydrochloride 0.2%
Microneedling with topical glycolic acid 35%.
OXP005
INT-747
CJ-12420 200mg + Clarithromycin 500mg
View Full List
CROs by country
Contract Research Organizations in Benin
Contract Research Organizations in Colombia
Contract Research Organizations in Croatia
Contract Research Organizations in Guinea
Contract Research Organizations in Jordan
Contract Research Organizations in Kosovo
Contract Research Organizations in Mali
Contract Research Organizations in Mauritania
Contract Research Organizations in Nigeria
Contract Research Organizations in Norway
Contract Research Organizations in Peru
Contract Research Organizations in Singapore
Contract Research Organizations in South Africa
CRO list by country
CROs in Oman
SGS
All CROs in Oman
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe